RICK Blocking Peptide

Formulation: 200 µg of peptide

Shelf life (days): 1095

Notes: To be used in conjunction with Cayman’s RICK polyclonal antibody (Catalog No. 160785) to block protein-antibody complex formation during immunochemical analysis of RICK · Apoptosis is mediated by death domain (DD) and/or caspase recruitment domain (CARD) containing molecules and a caspase family of proteases. DD-containing serine/threonine kinase RIP regulates Fas-induced apoptosis. A novel CARD-containing serine/threonine kinase that regulates apoptosis was recently identified and designated RICK for RIP-like interacting CLARP kinase.{7167} RICK contains an N-terminal kinase catalytic domain and a C-terminal CARD domain. The RICK kinase domain has high sequence homology to that of RIP. Overexpression of RICK promotes the activation of caspase-8 and Fas-induced apoptosis. RICK represents a novel kinase that regulates Fas-induced apoptosis. The mRNA for RICK is expressed in multiple human tissues.{7167}

• SKU: CAY301785
• Manufacturer: Cayman Chemical
• Manufacturer SKU: 301785-200
• Package Unit: 200 µg
• Quantity Unit: STK
• Application: Western Blotting